North Male Formula
Natural health product licensed in Canada
- Other names
- Evernate PANAX GINSENG GINKGO BILOBA ASHWAGANDHA & MACA, Havasu Ashwagandha, Maca, Ginseng & L-Arginine, Kasha Nutrition Ashwagandha Maca Tongkat Ali L-Arginine Panax Ginseng Ginkgo Tribulus, Kasha Nutrition Ashwagandha, Maca, Tongkat Ali, L-Arginine, Panax Ginseng, Ginkgo, Tribulus, Nutravonic Nutrition Ashwagandha, Maca, Tongkat Ali, L-Arginine, Panax Ginseng, Ginkgo, Tribulus, Nutristic Male Formula
- Licence holder
- NorthMED Life Sciences Inc.
- NPN or DIN-HM
- 80070972
- Status
- Active licence
- Licence date
- 8 July 2016
- Revision date
- 9 October 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 3,000 milligramme Potency : 6 % Terpene lactones | 30 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 100 milligramme | 5 milligramme | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 milligramme | 25 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 milligramme Potency : 7 % Total ginsenosides | 100 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 200 milligramme | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 1,500 milligramme | 50 milligramme | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to support emotional aspects of sexual health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, if you are taking antidepressants, if you are taking digoxin, if you have high blood pressure, if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression or if you have diabetes.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
Source
Official Health Canada record, licence 80070972
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.